![Cancers | Free Full-Text | Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma Cancers | Free Full-Text | Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma](https://pub.mdpi-res.com/cancers/cancers-13-03540/article_deploy/html/images/cancers-13-03540-g001.png?1626342517)
Cancers | Free Full-Text | Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma
![111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer | Journal of Nuclear Medicine 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/48/8/1357/F1.large.jpg)
111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer | Journal of Nuclear Medicine
![Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® with a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology | SpringerLink Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® with a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40259-020-00407-0/MediaObjects/40259_2020_407_Fig1_HTML.png)
Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® with a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology | SpringerLink
![EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents](https://patentimages.storage.googleapis.com/43/0c/56/8e7a4a9982ee18/imgb0003.png)
EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents
![Frontiers | A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo Frontiers | A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo](https://www.frontiersin.org/files/Articles/669393/fonc-11-669393-HTML/image_m/fonc-11-669393-g001.jpg)
Frontiers | A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo
Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
![EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents](https://patentimages.storage.googleapis.com/c2/87/b1/fd3e4a20379494/imgb0009.png)
EP2540745A9 - Fully humanized anti-her2 antibody, preparation method and use thereof - Google Patents
![Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab - ScienceDirect Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708511003785-gr2.jpg)
Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab - ScienceDirect
![Targeted Intracellular Delivery of Trastuzumab Using Designer Phage Lambda Nanoparticles Alters Cellular Programs in Human Breast Cancer Cells | ACS Nano Targeted Intracellular Delivery of Trastuzumab Using Designer Phage Lambda Nanoparticles Alters Cellular Programs in Human Breast Cancer Cells | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.1c02864/asset/images/large/nn1c02864_0008.jpeg)
Targeted Intracellular Delivery of Trastuzumab Using Designer Phage Lambda Nanoparticles Alters Cellular Programs in Human Breast Cancer Cells | ACS Nano
![Sequence by MALDI and ESI of Herceptin and 5G4 mAb. The proteolytic... | Download Scientific Diagram Sequence by MALDI and ESI of Herceptin and 5G4 mAb. The proteolytic... | Download Scientific Diagram](https://www.researchgate.net/publication/332994369/figure/fig1/AS:757043019403269@1557504529791/Sequence-by-MALDI-and-ESI-of-Herceptin-and-5G4-mAb-The-proteolytic-degradation-of-the.png)
Sequence by MALDI and ESI of Herceptin and 5G4 mAb. The proteolytic... | Download Scientific Diagram
![Structure of trastuzumab (Herceptin) Fab in complex with extracellular... | Download Scientific Diagram Structure of trastuzumab (Herceptin) Fab in complex with extracellular... | Download Scientific Diagram](https://www.researchgate.net/publication/40908230/figure/fig6/AS:642852031823873@1530279276800/Structure-of-trastuzumab-Herceptin-Fab-in-complex-with-extracellular-domain-of-HER2-is.png)
Structure of trastuzumab (Herceptin) Fab in complex with extracellular... | Download Scientific Diagram
![CDR regions of Trastuzumab F(ab') 2 Light Chain and Heavy Chain Based... | Download Scientific Diagram CDR regions of Trastuzumab F(ab') 2 Light Chain and Heavy Chain Based... | Download Scientific Diagram](https://www.researchgate.net/publication/317043608/figure/fig5/AS:497238611894275@1495562331735/CDR-regions-of-Trastuzumab-Fab-2-Light-Chain-and-Heavy-Chain-Based-on-analysis-of-CDR.png)
CDR regions of Trastuzumab F(ab') 2 Light Chain and Heavy Chain Based... | Download Scientific Diagram
![Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab - RSC Advances (RSC Publishing) DOI:10.1039/C6RA04337B Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab - RSC Advances (RSC Publishing) DOI:10.1039/C6RA04337B](https://pubs.rsc.org/image/article/2016/RA/c6ra04337b/c6ra04337b-f3_hi-res.gif)
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab - RSC Advances (RSC Publishing) DOI:10.1039/C6RA04337B
Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme | Journal of Proteome Research
![Sequence coverage obtained by CESI-MS/MS for trastuzumab (left-hand... | Download Scientific Diagram Sequence coverage obtained by CESI-MS/MS for trastuzumab (left-hand... | Download Scientific Diagram](https://www.researchgate.net/publication/269282654/figure/fig3/AS:669588631072777@1536653778715/Sequence-coverage-obtained-by-CESI-MS-MS-for-trastuzumab-left-hand-side-and.png)